Assessing incremental value of biomarkers with multi-phase nested case-control studies
DOI10.1111/BIOM.12344zbMATH Open1419.62495OpenAlexW1490191373WikidataQ36761375 ScholiaQ36761375MaRDI QIDQ2809548FDOQ2809548
Authors: Qian M. Zhou, Yingye Zheng, Lori B. Chibnik, Elizabeth W. Karlson, Tianxi Cai 
Publication date: 30 May 2016
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc4819437
Recommendations
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- Evaluating the predictive value of biomarkers with stratified case-cohort design
- Evaluating prognostic accuracy of biomarkers in nested case-control studies
- Improving efficiency in biomarker incremental value evaluation under two-phase designs
- Robust risk prediction with biomarkers under two-phase stratified cohort design
inverse probability weightingrisk predictionnested case-control studyincremental valuerheumatoid arthritistime dependent ROC curve analysis
Estimation in survival analysis and censored data (62N02) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Cites Work
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
- Evaluating prognostic accuracy of biomarkers in nested case-control studies
- Evaluating Prediction Rules fort-Year Survivors With Censored Regression Models
- Estimating the Error Rate of a Prediction Rule: Improvement on Cross-Validation
- A pseudolikelihood approach to analysis of nested case-control studies
- Retrospective studies and failure time models
- Weighted analyses for cohort sampling designs
- Asymptotic theory for nested case-control sampling in the Cox regression model
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- Resampling Procedures for Making Inference Under Nested Case–Control Studies
Cited In (6)
- Nonparametric Maximum Likelihood Estimators of Time-Dependent Accuracy Measures for Survival Outcome Under Two-Stage Sampling Designs
- Nonparametric Evaluation of Biomarker Accuracy Under Nested Case-Control Studies
- New weighting methods when cases are only a subset of events in a nested case‐control study
- Statistical inference for net benefit measures in biomarker validation studies
- Incorporating monotonicity into the evaluation of a biomarker
- A semiparametric method for risk prediction using integrated electronic health record data
This page was built for publication: Assessing incremental value of biomarkers with multi-phase nested case-control studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2809548)
